GDRX
GoodRx Holdings, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
23.08
PEG
0.99
P/B
1.13
P/S
0.88
EV/EBITDA
2.71
DCF Value
$4.58
FCF Yield
15.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.1%
Operating Margin
11.2%
Net Margin
3.8%
ROE
4.8%
ROA
3.3%
ROIC
4.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $194.8M | $5.4M | $0.02 |
| FY 2025 | $796.9M | $30.4M | $0.09 |
| Q3 2025 | $196.0M | $1.1M | $0.00 |
| Q2 2025 | $203.1M | $12.8M | $0.04 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.47
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.